-+ 0.00%
-+ 0.00%
-+ 0.00%

bioAffinity Technologies says Mexico allows patent covering CyPath Lung cancer detection methods

PUBT·05/27/2026 12:03:50
Listen to the news
bioAffinity Technologies says Mexico allows patent covering CyPath Lung cancer detection methods
  • bioAffinity Technologies received a Mexico notice of allowance for a patent covering lung cancer detection methods used in its CyPath Lung test.
  • Application covers labeling sputum cell populations with defined antibodies and porphyrin TCPP, then using flow cytometry to detect lung cancer cells.
  • Move expands IP protection for the flow cytometry-based platform, which already holds patents across major markets including the US, EU, China, Japan, Australia, Canada.


Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. bioAffinity Technologies Inc. published the original content used to generate this news brief via Business Wire (Ref. ID: 20260527333514) on May 27, 2026, and is solely responsible for the information contained therein.